Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Circulation Research, Ovid Technologies (Wolters Kluwer Health), Vol. 109, No. suppl_1 ( 2011-12-09)
    Abstract: The source of Ca 2+ to hypertrophic signaling after myocardial infarction (MI) is not clearly defined. Transient Receptor Potential Canonical (TRPC) channels could be an important source of hypertrophic Ca 2+ after MI. The objective of this study was to determine if TRPC 4 is a major source of Ca 2+ influx mediating cardiac dysfunction after MI. Methods: Cardiac-specific transgenic mice that express a dominant-negative (dn) TRPC4 that reduces the activity of the TRPC1/4/5 subfamily of channels in the heart were used. MI was produced and in-vivo cardiac function was measured with ECHO. Myocytes were isolated and isoproterenol (ISO) effects on LTCC Current ( I Ca-L ), fractional shortening (FS) and Ca 2+ transients were measured 6 weeks after MI. Results: Baseline ejection fraction (EF) and fractional shortening (FS) were greater in (dn) TRPC4 vs. WT mice. Two weeks after MI, EF and FS were significantly decreased in all animals (WT: 37.1% and 18.2%; (dn) TRPC4: 41.7% and 20.5%), but there was no significant difference between WT and (dn) TRPC4 mice. Six weeks after MI, EF and FS were significant greater in (dn) TRPC4 compared with WT mice (WT: 37.4% and 18.2%; (dn) TRPC4: 52.2% and 27.4%). Heart weight and lung weight were significantly increased after 2 weeks MI, but there were significant lower heart and lung weight in (dn) TRPC4 vs. WT mice after 6 weeks MI. I Ca-L [[Unsupported Character - Codename & shy;]] after 6 weeks MI was smaller than that in sham myocytes, and there was no significant difference between (dn) TRPC4 and WT myocytes. Contractions and Ca 2+ transients were significantly greater in sham and post-MI (dn) TRPC4 vs. WT myocytes. ISO increased contractions and Ca 2+ transients to a similar extent in all myocytes. Conclusions: (dn) TRPC4 mice have greater baseline cardiac and myocyte function. While initial effects of MI were similar to control, there was improved function in these mice by 6 weeks. These results suggest that blocking TRPC4 after MI may reduce pathological cardiac remodeling.
    Type of Medium: Online Resource
    ISSN: 0009-7330 , 1524-4571
    RVK:
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2011
    detail.hit.zdb_id: 1467838-X
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    In: Circulation Research, Ovid Technologies (Wolters Kluwer Health), Vol. 113, No. suppl_1 ( 2013-08)
    Abstract: Hypothesis: Ca2+ influx through transient receptor potential canonical (TRPC) channels and L-type Ca2+ channels (LTCCs) within caveolin-3 (Cav3) stabilized signaling microdomains provide a unique source of Ca2+ to activate pathologic cardiac hypertrophy through calcineurin (Cn)-mediated nuclear factor of activated T-cells (NFAT) signaling. We suggest that a distinct and separate population of TRPC channels localized in excitation-contraction (EC) coupling microdomains may have potent effects on myocyte contractility independent of Cav3 signaling domains. Methods and Results: Membrane localization studies and immunohistochemistry show that TRPC channels and LTCCs co-localize to Cav3 signaling microdomains. To explore a role for these caveolae based Ca2+ channels in the initiation of Cn-NFAT signaling we used an adenoviral NFAT-GFP reporter in cultured adult feline myocytes (AFMs). Infecting AFMs with ad-TRPC3 dramatically increased NFAT translocation, which was inhibited with dominant negative ad-dnTRPC6. Expression of a Cav3 targeted LTCC blocker (ad-Cav-Rem) reduced NFAT translocation while a targeted LTCC activator (ad-Cav-β2a) significantly increased NFAT activation. Neither LTCC modulator had significant effects on Ca2+ current or contractility in AFMs but we found that the expression of TRPC3 reduced myocyte contractility and induced spontaneous Ca2+ spark activity that was exacerbated by the DAG activator OAG. Moreover, dnTRPC6 blocked spontaneous Ca2+ sparks even in the presence of OAG. Immunohistochemistry analysis revealed the presence of TRPC channels in transverse tubules, consistent with the idea that they could have direct effects on EC coupling microdomains. Conclusions: Our data show that TRPC channels and LTCCs co-localize to Cav3 signaling domains where they generate a unique Ca2+ microenvironment that directly regulates Cn-NFAT signaling. Our findings also suggest that a separate and distinct population of TRPC channels within EC coupling microdomains cause reduced myocyte contractility by inducing SR Ca2+ leak and Ca2+ spark activity.
    Type of Medium: Online Resource
    ISSN: 0009-7330 , 1524-4571
    RVK:
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2013
    detail.hit.zdb_id: 1467838-X
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    In: Circulation Research, Ovid Technologies (Wolters Kluwer Health), Vol. 110, No. 5 ( 2012-03-02), p. 669-674
    Abstract: The source of Ca 2+ to activate pathological cardiac hypertrophy is not clearly defined. Ca 2+ influx through the L-type Ca 2+ channels (LTCCs) determines “contractile” Ca 2+ , which is not thought to be the source of “hypertrophic” Ca 2+ . However, some LTCCs are housed in caveolin-3 (Cav-3)–enriched signaling microdomains and are not directly involved in contraction. The function of these LTCCs is unknown. Objective: To test the idea that LTCCs in Cav-3–containing signaling domains are a source of Ca 2+ to activate the calcineurin–nuclear factor of activated T-cell signaling cascade that promotes pathological hypertrophy. Methods and Results: We developed reagents that targeted Ca 2+ channel-blocking Rem proteins to Cav-3–containing membranes, which house a small fraction of cardiac LTCCs. Blocking LTCCs within this Cav-3 membrane domain eliminated a small fraction of the LTCC current and almost all of the Ca 2+ influx-induced NFAT nuclear translocation, but it did not reduce myocyte contractility. Conclusions: We provide proof of concept that Ca 2+ influx through LTCCs within caveolae signaling domains can activate “hypertrophic” signaling, and this Ca 2+ influx can be selectively blocked without reducing cardiac contractility.
    Type of Medium: Online Resource
    ISSN: 0009-7330 , 1524-4571
    RVK:
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2012
    detail.hit.zdb_id: 1467838-X
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    Ovid Technologies (Wolters Kluwer Health) ; 2012
    In:  Circulation Research Vol. 111, No. suppl_1 ( 2012-08-03)
    In: Circulation Research, Ovid Technologies (Wolters Kluwer Health), Vol. 111, No. suppl_1 ( 2012-08-03)
    Abstract: T-type Ca²[[Unable to Display Character: + ]] channels (TTCC) are primarily expressed in fetal/neonatal cardiomyocytes and their functional role is not well defined. Here we explored the idea that Ca 2+ influx through TTCC regulates myocyte proliferation. The fact that Mibefradil (TTCC and L-type calcium channel (LTCC) antagonist) inhibits smooth muscles proliferation supports this idea. Our hypothesis is: Blocking TTCC will reduce neonatal cardiomyocyte proliferation. Wild type (WT) and α1G TTCC knockout (α1G-/-) neonatal mice ventricular myocytes (NMVMs) were used. Patch clamp was used to measure TTCC. Flow cytometry was used to determine cell cycle distribution. 1. On day 1 (after birth), TTCC was detected in 35% WT NMVMs (n=31), whereas only 4% α1G-/- NMVMs have TTCC (n=25). On day 7, no TTCC was detected in both WT (n=16) and α1G-/- (n=27). 2. In vivo: On day 1 there’s no significant difference in cell cycle distribution: [88.2%±2.7% in G1/G0, 8.1%±2.8% in G2/M, 3.2%±0.1% in S; n=12] in WT vs. [90.6%±1.6% in G1/G0, 5.7%±1.5% in G2/M, 3.7%±0.3% in S; n=20] in α1G-/-. On day 7 there’s a significant difference: [52.3%±1.6% in G1/G0, 47.7%±1.6% in G2/M; n=28] in WT vs. [68.2%±2.1% in G1/G0, 31.9%±2.1% in G2/M; n=20] in α1G-/-, p 〈 0.05. 3. In vitro: Mono and binucleated myocytes percentage was measured: On day 1 there’s no significant difference. On day 7 there were more binucleated cells in WT: 51%±4% mono and 49%±4% binucleated in WT (n=495) vs. 80%±3% mono and 20%±3% binucleated in α1G-/- (n=1107), p 〈 0.05. Cell surface area (CSA) (um²) in α1G-/- (n=164) was smaller than WT (n=109): 860.3±323.3 in WT vs. 716.7±274.9 in α1G-/- in mono (p 〈 0.005), 1333.9±534.0 in WT vs. 1016.6±315.4 in α1G-/- in binucleated (p 〈 0.001). In 2-month old mice there’s a difference in percentage of mono and binucleated myocytes: [7.3%±3.7% mono, 92.7%±3.6% binucleated; n=687] in WT vs. [30.8%±6.1% mono, 69.2%±6.1% binucleated; n=793] in α1G-/-, p 〈 0.05. CSA in α1G-/- was smaller than in WT: 2267.4±1119.7 in WT vs. 1784.6±683.9 in α1G-/- in mononulceated (p 〈 0.0001), 2419.2±712.4 in WT vs. 2048.3±671.1 in α1G-/- in binucleated (p 〈 0.0001). There is large amount of DNA synthesis in NMVMs after birth, by day 7 most of the WT NMVMs are arrested in G2 and become binucleated. Myocyte without α1G TTCCs did not exit from the cell cycle normally.
    Type of Medium: Online Resource
    ISSN: 0009-7330 , 1524-4571
    RVK:
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2012
    detail.hit.zdb_id: 1467838-X
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    In: Circulation Research, Ovid Technologies (Wolters Kluwer Health), Vol. 111, No. suppl_1 ( 2012-08-03)
    Abstract: Introduction: The source of Ca 2+ that activates pathological cardiac hypertrophy is not clearly defined. We hypothesize that high activity gating of L-type Ca 2+ channels (LTCCs) localized in caveolae signaling microdomains stabilized by caveolin-3 (Cav-3) provides the Ca 2+ influx that locally activates calcineurin (Cn)-mediated nuclear factor of activated T-cells (NFAT) to induce hypertrophic gene expression. We generated novel reagents that specifically activate or inhibit the gating of LTCCs in caveolae for analysis of the hypertrophic program, as well as any potential effect on ICa and contraction. Methods and Results: We targeted the known LTCC inhibitory protein Rem or an LTCC subunit (β2a) that promotes high activity gating specifically to caveolae by fusing them to a caveolin-binding domain peptide (termed Cav-Rem and Cav-β2a). We infected adult feline left ventricular myocytes (AFLVMs) with adenoviruses containing Cav-Rem or Cav-β2a for membrane localization and functional studies. NFAT nuclear translocation was determined by co-infecting AFLVMs with ad-NFAT-GFP and either ad-Cav-Rem or ad-Cav-β2a and pacing cells to induce Ca2+ influx mediated nuclear NFAT-GFP translocation. Membrane fractionation experiments showed that Cav-3 membrane domains contain 26.2 +/- 12.7% of membrane targeted LTCCs and blocking these with Cav-Rem eliminated a small fraction of the LTCC current ( 〈 15%) and almost all Ca2+ influx induced NFAT nuclear translocation ( 〉 90%), but did not reduce myocyte contractility. Conversely, selective enhancement of LTCC activity within caveolae with Cav-β2a caused a significant increase in NFAT nuclear translocation ( 〉 70%) but had no significant effect on contractility. Conclusions: We provide proof of concept that specific Cav-targeted reagents can be used to enhance or inhibit LTCC activity within caveolae microdomains to amplify or block the hypertrophic response. Our results suggest that high activity gating of LTCCs, which is known to be present in the hypertrophied failing human heart, can activate signaling pathways linked to cardiac hypertrophy. Selectively inhibiting these caveolae localized LTCCs could be a novel mechanism to block pathological hypertrophy without reducing cardiac contractility.
    Type of Medium: Online Resource
    ISSN: 0009-7330 , 1524-4571
    RVK:
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2012
    detail.hit.zdb_id: 1467838-X
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages